Mercy Health Ohio

Quick facts

Marketed products

• Cefazolin + Gentamicin · Infectious Disease
  This combination uses a beta-lactam antibiotic (cefazolin) to inhibit bacterial cell wall synthesis and an aminoglycoside (gentamicin) to inhibit bacterial protein synthesis, providing synergistic broad-spectrum bactericidal activity.
• Clindamycin + Gentamicin · Infectious Disease
  Clindamycin and gentamicin are a combination antibiotic therapy that inhibits bacterial protein synthesis through different mechanisms to provide broad-spectrum coverage against aerobic and anaerobic pathogens.
• Methylprednisolone Injection [Solu-Medrol] · Immunology, Rheumatology, Oncology (supportive care)
  Methylprednisolone is a synthetic corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Phase 3 pipeline

• Droperidol Injectable Product · Psychiatry / Acute Care
  Droperidol is a butyrophenone antipsychotic that blocks dopamine receptors in the central nervous system, reducing agitation and providing antiemetic effects.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mercy Health Ohio portfolio CI brief
• Mercy Health Ohio pipeline updates RSS